D

Decrypt Biomedicine

10 employees

Decrypt Biomedicine develops small-molecule drugs targeting cryptic binding sites on proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2022

Funding rounds raised

D

Decrypt Biomedicine raised undisclosed on December 1, 2022

Investors: Curie.Bio and Caffeinated Capital

FAQ